Sickle cell disease is a painful and debilitating genetic condition. It affects over 100,000 people in the U.S. and more than 20 million globally鈥攎ost are Black or of African origin. Until recently, sickle cell was considered a lifelong disease. Then, in 2019, Victoria Gray became the first patient cured using CRISPR gene-editing technology.
On July 13, Victoria Gray will come to 黑料吃瓜资源 (CSHL) to share her experience. Join CSHL for a free, in-person 鈥溾�� event, where Gray will discuss sickle cell with a group of high schoolers from the DNA Learning Center鈥檚 STARS program. Gray will reflect on her personal journey living with the disease. She鈥檒l also talk about treatment challenges and the newfound hope for patients with genetic disorders. Additionally, scientists and physicians will join the discussion to speak out on the importance of making new scientific knowledge and medical treatments available to all communities.
The event will take place from 1 to 2 p.m. in CSHL’s Grace Auditorium. Registration is free but required. .
Written by: Communications Department | [email protected] | 516-367-8455